# Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme

> **NCT00004262** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 12 (estimated)

## Conditions studied

- Adult Giant Cell Glioblastoma
- Adult Glioblastoma
- Adult Gliosarcoma

## Interventions

- **PROCEDURE:** conventional surgery
- **RADIATION:** 3-dimensional conformal radiation therapy
- **RADIATION:** stereotactic radiosurgery
- **DRUG:** motexafin gadolinium
- **PROCEDURE:** magnetic resonance imaging
- **PROCEDURE:** spectroscopy

## Key facts

- **NCT ID:** NCT00004262
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** 2005-05
- **Final completion:** —
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2013-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004262, "Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00004262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*